{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:35:24Z","timestamp":1784669724691,"version":"3.55.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T00:00:00Z","timestamp":1343088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041896","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T21:11:45Z","timestamp":1343164305000},"page":"e41896","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Oxidative Stress-Induced Glomerular Mineralocorticoid Receptor Activation Limits the Benefit of Salt Reduction in Dahl Salt-Sensitive Rats"],"prefix":"10.1371","volume":"7","author":[{"given":"Kento","family":"Kitada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cpt197721162","article-title":"Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.","volume":"21","author":"RK Ferguson","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.","volume":"41","author":"JM Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.","volume":"116","author":"SJ Hood","year":"2007","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10157-010-0298-8","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.","volume":"14","author":"M Nagase","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339911794273919","article-title":"Endocrinological aspects of proteinuria and podocytopathy in diabetes: role of the aldosterone\/mineralocorticoid receptor system.","volume":"7","author":"M Nagase","year":"2011","journal-title":"Curr Diabetes Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.10R07CR","article-title":"Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.","volume":"115","author":"K Rafiq","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00004872-199512010-00054","article-title":"Albuminuria in untreated patients with primary aldosteronism or essential hypertension.","volume":"13","author":"JM Halimi","year":"1995","journal-title":"J Hypertens"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism.","volume":"33","author":"M Nishimura","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.ajkd.2005.03.007","article-title":"Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.","volume":"46","author":"S Bianchi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.","volume":"112","author":"M Quinkler","year":"2005","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"F802","DOI":"10.1152\/ajprenal.00197.2009","article-title":"Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.","volume":"297","author":"J Du","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/ndt\/gfq197","article-title":"Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.","volume":"25","author":"H Kawarazaki","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","article-title":"Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.","volume":"47","author":"M Nagase","year":"2006","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.109.158113","article-title":"Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.","volume":"332","author":"A Nishiyama","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.107.098012","article-title":"Mineralocorticoid receptor activation and oxidative stress.","volume":"50","author":"JW Funder","year":"2007","journal-title":"Hypertension"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor.","volume":"53","author":"JW Funder","year":"2009","journal-title":"Hypertension"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HJH.0b013e32834103a9","article-title":"Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats.","volume":"29","author":"K Rafiq","year":"2011","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1210\/en.2007-0209","article-title":"Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid\/salt administration?","volume":"148","author":"AJ Rickard","year":"2007","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/HJH.0b013e3283346b62","article-title":"Involvement of mineralocorticoid receptor in high glucose-induced big mitogen-activated protein kinase 1 activation and mesangial cell proliferation.","volume":"28","author":"G Liu","year":"2010","journal-title":"J Hypertens"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","article-title":"Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.","volume":"121","author":"S Shibata","year":"2011","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease.","volume":"14","author":"S Shibata","year":"2008","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1681\/ASN.2007121271","article-title":"High perfusion pressure accelerates renal injury in salt-sensitive hypertension.","volume":"19","author":"T Mori","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/01.HYP.0000160404.08866.5a","article-title":"Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.","volume":"45","author":"N Tian","year":"2005","journal-title":"Hypertension"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"R1858","DOI":"10.1152\/ajpregu.90650.2008","article-title":"NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension.","volume":"295","author":"N Tian","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"H3388","DOI":"10.1152\/ajpheart.00981.2007","article-title":"Interactions between oxidative stress and inflammation in salt-sensitive hypertension.","volume":"293","author":"N Tian","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/01.HYP.0000070028.99408.E8","article-title":"Oxidative stress in Dahl salt-sensitive hypertension.","volume":"41","author":"S Meng","year":"2003","journal-title":"Hypertension"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjhyper.2004.11.045","article-title":"Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats.","volume":"18","author":"R Hisaki","year":"2005","journal-title":"Am J Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10641960500468276","article-title":"Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.","volume":"28","author":"MA Bayorh","year":"2006","journal-title":"Clin Exp Hypertens"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.ASN.0000113244.37857.AC","article-title":"Aldosterone decreases UT-A1 urea transporter expression via the mineralocorticoid receptor.","volume":"15","author":"RA Gertner","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1681\/ASN.2004080649","article-title":"Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.","volume":"16","author":"Y Nagai","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/01.hjh.0000182523.29193.e3","article-title":"D-allose, an all-cis aldo-hexose, suppresses development of salt-induced hypertension in Dahl rats.","volume":"23","author":"S Kimura","year":"2005","journal-title":"J Hypertens"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0b013e328336ade3","article-title":"Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.","volume":"28","author":"YY Fan","year":"2010","journal-title":"J Hypertens"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.HYP.0000154681.38944.9a","article-title":"Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability.","volume":"45","author":"A Nishiyama","year":"2005","journal-title":"Hypertension"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M607741200","article-title":"Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.","volume":"282","author":"K Yokota","year":"2007","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tem.2004.03.009","article-title":"Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products.","volume":"15","author":"A Bhargava","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000256665","article-title":"Aldosterone promotes fibronectin synthesis in rat mesangial cells via ERK1\/2-stimulated Na-H+ exchanger isoform 1.","volume":"31","author":"M Zhang","year":"2010","journal-title":"Am J Nephrol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3109\/08860220903134571","article-title":"The role of Na+-H+ exchanger isoform 1 in aldosterone-induced glomerulosclerosis in vivo.","volume":"31","author":"M Zhang","year":"2009","journal-title":"Ren Fail"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.","volume":"54","author":"AS Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2007.10.040","article-title":"Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.","volume":"51","author":"AS Bomback","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11906-009-0061-2","article-title":"Effect of blood pressure lowering on markers of kidney disease progression.","volume":"11","author":"SM Udani","year":"2009","journal-title":"Curr Hypertens Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.ASN.0000108523.02100.E0","article-title":"The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats.","volume":"15","author":"A Nishiyama","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/HJH.0b013e328338bb37","article-title":"Blockade of mineralocorticoid receptors improves salt-induced left-ventricular systolic dysfunction through attenuation of enhanced sympathetic drive in mice with pressure overload.","volume":"28","author":"K Ito","year":"2010","journal-title":"J Hypertens"},{"key":"ref43","article-title":"The role of mineralocorticoid action in the brain in salt-sensitive hypertension.","author":"K Oki","year":"2011"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","article-title":"Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.","volume":"297","year":"1988","journal-title":"BMJ"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1210\/en.2004-0295","article-title":"Origin of aldosterone in the rat heart.","volume":"145","author":"EP Gomez-Sanchez","year":"2004","journal-title":"Endocrinology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.279.17.1383","article-title":"Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis.","volume":"279","author":"NA Graudal","year":"1998","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-201x.2002.00937.x","article-title":"Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat.","volume":"174","author":"G Hodge","year":"2002","journal-title":"Acta Physiol Scand"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.HYP.15.4.376","article-title":"Time course of enhanced adrenal responsiveness to angiotensin on a low salt diet.","volume":"15","author":"S Rogacz","year":"1990","journal-title":"Hypertension"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.HYP.0000094220.06020.C8","article-title":"In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.","volume":"42","author":"MS Zhou","year":"2003","journal-title":"Hypertension"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.HYP.0000136395.06810.cf","article-title":"Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.","volume":"44","author":"MS Zhou","year":"2004","journal-title":"Hypertension"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"R395","DOI":"10.1152\/ajpregu.00731.2004","article-title":"SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess.","volume":"289","author":"V Vallon","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.111.242719","article-title":"Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in dahl salt-sensitive rats.","volume":"32","author":"S Morizane","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2009.09.005","article-title":"Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.","volume":"623","author":"T Mori","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.2011.574","article-title":"Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.","volume":"305","author":"K Stolarz-Skrzypek","year":"2011","journal-title":"JAMA"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217","article-title":"Reduced dietary salt for the prevention of cardiovascular disease.","author":"RS Taylor","year":"2011"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review).","volume":"24","author":"RS Taylor","year":"2011","journal-title":"Am J Hypertens"},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2011.1291","article-title":"Urinary sodium excretion and cardiovascular disease mortality.","author":"K Aleksandrova","year":"2011"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(11)61174-4","article-title":"Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.","volume":"378","author":"FJ He","year":"2011","journal-title":"Lancet"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2011.1292","article-title":"Urinary sodium excretion and cardiovascular disease mortality.","author":"CM Rebholz","year":"2011"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:51:34Z","timestamp":1589043094000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041896"}},"subtitle":[],"editor":[{"given":"Nick","family":"Ashton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041896","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]}}}